The Disease Centered Multimorbidity Model at the Example of Type 2 Diabetes Mellitus

  • Dmitry Meshkov V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Alexey Lobanov V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Larisa Danilova Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus
  • Sergey Cherkasov V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Alexander Shiroky V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Anna Fedyaeva V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Irina Moroz Belarusian State Medical University, Minsk, Belarus
  • Elena Makeeva V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
Keywords: multimorbidity, multimorbidity pattern, Type 2 Diabetes Mellitus, expert support, decision making, patient-centered healthcare, cumulative life course impairment, proactive risk management, healthcare

Abstract

Multimorbidity is a condition when few diseases (multimorbidity pattern) are diagnosed in same patient. According to the disease centered model the pattern is formed around one “marker” disease at the expense of other diseases which have non-random relationships with the “marker” disease and between each other. The totality and probabilistic connections between pairs of diseases determine the specifics of the pattern and indicate the possibilities for managing individual and population health as a result of interactions of all components of the the pattern. Algorithms have been developed assessing the degree of non-random connections between pairs of diseases in the pattern and establishing a hierarchical relationship between both “marker” and other diseases as well as between pairs of non-marker diseases. The calculation of non-random statistical relationships between pairs of diseases included in the T2DM (Type 2 Diabetes Mellitus) multimorbidity pattern proved the consistency of the data obtained with the current clinical description of T2DM pathogenesis and complications.

Published
2023-04-16